|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000268 |
Purpose
The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder
| Condition | Intervention |
|---|---|
|
Cocaine-Related Disorders |
Drug: Bupropion |
| Study Type: | Interventional |
| Study Design: | Treatment, Single Group Assignment |
| Official Title: | Cocaine Abuse and Attention Deficit Disorder |
| Estimated Enrollment: | 32 |
| Study Start Date: | May 1995 |
| Estimated Study Completion Date: | November 1998 |
To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
current adult ADHD current cocaine dependence
Exclusion Criteria:
no current major depression
Contacts and Locations| United States, New York | |
| New York State Psychiatric Institute | |
| New York, New York, United States, 10032 | |
| Principal Investigator: | Herbert Kleber, M.D. | New York State Psychiatric Institute |
More Information
| Study ID Numbers: | NIDA-09236-3, P50-09236-3 |
| Study First Received: | September 20, 1999 |
| Last Updated: | November 3, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000268 |
| Health Authority: | United States: Federal Government |
|
Cocaine-Related Disorders Attention Deficit Disorder with Hyperactivity Mental Disorders Bupropion Mental Disorders Diagnosed in Childhood |
Substance-Related Disorders Attention Deficit and Disruptive Behavior Disorders Disorders of Environmental Origin Hyperkinesis Cocaine |
|
Pathologic Processes Disease |
